ALGS · Stage, GEX levels and seasonality
Aligos Therapeutics, Inc. Common Stock (ALGS)
Last close $5.63 (+0.18%) on 2026-09-30
No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.
Open the chartWeinstein stage
Stage 4B — Declining · 27 weeks in this stage · 30-week average $6.08
Stage 4 (declining): price stays below a falling 30-week average. The stage Weinstein avoids.
What would change it: Stage 1 begins when the 30-week SMA (6.08) stops declining and price starts closing above it.
GEX levels
Call wall, put wall and gamma flip for ALGS are on Signa plans. What GEX levels tell you.
Seasonality
| Month | Average return | Months up | Years |
|---|---|---|---|
| January | +9.97% | 50% | 4 |
| February | -1.07% | 25% | 4 |
| March | -26.69% | 25% | 4 |
| April | -3.52% | 25% | 4 |
| May | -9.13% | 25% | 4 |
| June | -3.2% | 25% | 4 |
| July | +0.13% | 25% | 4 |
| August | +22.78% | 75% | 4 |
| September | -16.2% | 0% | 4 |
| October (this month) | +0.23% | 67% | 3 |
| November | +58.49% | 67% | 3 |
| December | +20.08% | 33% | 3 |
Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.
On Signa plans
The Signa score and Action Card for ALGS, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.
No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.
Questions about ALGS
What Weinstein stage is ALGS in?
ALGS is in Stage 4B — Declining, for 27 weeks, based on completed weekly bars and its 30-week moving average (6.08).
How has ALGS done in October?
Over the last 3 years, ALGS averaged +0.23% in October and rose in 67% of them. Past seasonality does not predict future returns.
Educational content only, not financial advice. Trading involves substantial risk.